Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Orion Pharma
Woman and Man Max 99 years
Orion Pharma
Update Il y a 4 ans
Non-inferiority study; Comparison of polyethylene glycol solution with and without electrolytes for treatment of chronic constipation in elderly institutionalised patients: a double-blind, randomised, parallelgroup, multicentre study
The primary objective of the study is to show non-inferiority of hypotonic PEG product to isotonic PEG product in efficacy in elderly institutionalised patients. The other main objective is to demonst...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Orion Pharma
Update Il y a 4 ans
Étude 3124001 : étude de phase 1-2 évaluant la tolérance, la sécurité et l’efficacité de l’ODM-208 chez des patients ayant un cancer de la prostate métastatique résistant à la castration.
Un cancer de la prostate est une maladie qui se développe à partir de cellules de la prostate initialement normales qui se transforment et se multiplient de façon anarchique, jusqu’à former une masse ...
Country
France
organs
Prostate
Specialty
Thérapies Ciblées
Essai ouvert aux inclusions
More information
Woman and Man Max 99 years
Orion Corporation Orion Pharma
Update Il y a 4 ans
Confronto degli effetti di due sedativi, la dexmedetomidina e il propofol, in pazienti che hanno bisogno di ricominciare a respirare senza un macchinario e che hanno difficolta' a farlo. A comparison of the effects of two calming drugs, dexmedetomidine and propofol, in patients who need to start breathing without the help of a machine and are having difficulty doing so
The primary objective is to investigate effects of dexmedetomidine on diaphragmatic neural activity (EAdi) over 24 hours after starting study treatment in difficult to wean mechanically ventilated p...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Orion Pharma
Update Il y a 4 ans
Efficacy and safety of ibuprofen 5% gel compared to placebo gel in patients who have uncomplicated ankle injuries with pain
The primary objective of the study is to evaluate the efficacy of Ibuprofen 5% gel versus placebo gel in human adult patients for the treatment of pain related to uncomplicated ankle injuries.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Orion Pharma
Update Il y a 4 ans
Efficacy and safety of ibuprofen 5 % roll-on gel compared to placebo roll-on gel in patients who have uncomplicated ankle injuries with pain
The primary objective of the study is to evaluate the efficacy of Ibuprofen 5% roll-on gel versus placebo roll-on gel in human adult patients for the treatment of pain related to uncomplicated ankle i...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Orion Corporation Orion Pharma
Update Il y a 4 ans
A study of ORM-12741 for the prevention of blood vessel spasm brought on by cold temperature
To evaluate the efficacy of ORM-12741 in the attenuation of a cold-induced reduction in finger blood flow and temperature in subjects with Raynaud's Phenomenon (RP) secondary to systemic sclerosis in...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Orion Pharma
Update Il y a 4 ans
Survival of patients with acute heart failure in need of intravenous inotropic support; a multicentre parallel- group, randomised, double- blind, double- dummy study of levosimendan versus dobutamine in patients with acute heart failure
The primary objective of the study is to compare the efficacy of levosimendan to dobutamine on "All-cause mortality" in the 180 days following randomisation.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Orion Corporation Orion Pharma
Update Il y a 4 ans
A PROSPECTIVE, MULTI-CENTRE, RANDOMISED, DOUBLE-BLIND COMPARISON OF INTRAVENOUS DEXMEDETOMIDINE WITH PROPOFOL FOR CONTINUOUS SEDATION OF VENTILATED PATIENTS IN INTENSIVE CARE UNIT
The study has hierarchical co-primary objectives to demonstrate that: • Firstly: dexmedetomidine is at least as effective as sedation with propofol and daily sedation stops, in maintaining a target de...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Orion Corporation Orion Pharma
Update Il y a 4 ans
A PROSPECTIVE, MULTI-CENTRE, RANDOMISED, DOUBLE-BLIND COMPARISON OF INTRAVENOUS DEXMEDETOMIDINE WITH MIDAZOLAM FOR CONTINUOUS SEDATION OF VENTILATED PATIENTS IN INTENSIVE CARE UNIT
The study has hierarchical co-primary objectives to demonstrate that: • Firstly: dexmedetomidine is at least as effective as sedation with midazolam and daily sedation stops, in maintaining a target d...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Orion Pharma
Update Il y a 4 ans
Étude KIDES-203 : étude de phase 1, de première administration chez l’homme, en escalade dose, évaluant la tolérance d’ODM-203, un inhibiteur de VEGFR/FGFR, chez des patients ayant une tumeur solide avancée. [essai clos aux inclusions]
L’ODM-203 est une petite molécule sélective inhibitrice des récepteurs FGFR et VEGFR, qui sont impliqués dans la survie du patient dans certains types de cancer (sein, poumon et estomac) et dans la pr...
Country
France
organs
Tumeurs solides
Specialty
Thérapies Ciblées
Essai clos aux inclusions
More information
Previous
1
2
3
Next